Significance of decreased apoptosis, role of Bid expression and Bcl‐Xl/Bid ratio in human jejunal stromal tumors


Source: Apmis, Volume 120, Number 3, 1 March 2012 , pp. 171-181(11)

Publisher: Wiley-Blackwell

Buy & download fulltext article:


Price: $48.00 plus tax (Refund Policy)


Gao C, Guo W‐J, Wang A‐Y. Significance of decreased apoptosis, role of Bid expression and Bcl‐Xl/Bid ratio in human jejunal stromal tumors. APMIS 2012; 120: 171–81.

Given that the studies on human small intestinal stromal tumors are very limited, our study was designed to determine the significance of apoptosis, the role of some apoptosis‐related proteins, including Bax, Bad, Bid, Bcl‐2, Bcl‐Xl, and Bcl‐W, in jejunal stromal tumors (JST). For this purpose, 52 samples were examined by terminal deoxynucleotidyl transferase‐mediated dUTP nick end labeling and immunohistochemistry, including 40 cases from normal jejunum and 12 cases from the JST. The results showed that a significantly decreased apoptosis was observed in JST compared with normal jejunum (median of apoptotic index, 0.13% vs 15.17%, p < 0.001). In univariate analysis, statistically significant differences were shown in percentage of positive‐expression of Bid (0.0% vs 77.5%, p < 0.001), Bcl‐2 (91.7% vs 42.5%, p = 0.003), and Bcl‐Xl (75.0% vs 35.0%, p = 0.014), but not in Bax, Bad, and Bcl‐W. Moreover, Bcl‐Xl was an independent parameter associated with JST by multivariate Logistic analysis. For the role of ratios of anti‐apoptotic proteins to pro‐apoptotic proteins, Bcl‐Xl/Bid ratio was the most preferable index. In conclusion, decreased apoptosis and expression of Bid, increased level of Bcl‐Xl may play some important roles in human JST, and Bcl‐Xl/Bid ratio may be as a new potentially associated index, although they should be validated in more studies.

Document Type: Research Article


Affiliations: Department of Gastroenterology, Peking University Third Hospital, Beijing

Publication date: March 1, 2012

Related content



Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page